Valuation: Becton, Dickinson and Company

Market Cap 48.82B 42.84B 40.46B 36.87B 69.02B 4,679B 69.51B 484B 188B 2,390B 183B 179B 7,683B P/E 2026 *
34.5x
P/E 2027 * 19.3x
Enterprise Value 64.7B 56.78B 53.62B 48.87B 91.48B 6,202B 92.13B 642B 249B 3,168B 243B 238B 10,182B EV / Sales 2026 *
3.36x
EV / Sales 2027 * 3.18x
Free-Float
73.18%
Yield 2026 *
2.19%
Yield 2027 * 2.23%
1 day-0.02%
1 week+0.38%
Current month-1.57%
1 month-2.56%
3 months+22.90%
6 months+18.35%
Current year-3.76%
1 week 157.1
Extreme 157.1
160.85
1 month 151.2
Extreme 151.2
164.25
Current year 121.45
Extreme 121.45
179.95
1 year 121.45
Extreme 121.45
179.95
3 years 121.45
Extreme 121.45
252.5
5 years 121.45
Extreme 121.45
264.8
10 years 121.45
Extreme 121.45
264.8
Manager TitleAgeSince
Chief Executive Officer 53 27/01/2020
Director of Finance/CFO 44 04/12/2025
Compliance Officer - 31/01/2023
Director TitleAgeSince
Director/Board Member 75 23/09/2002
Director/Board Member 71 25/07/2010
Chairman 53 27/04/2021
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+0.38% - - 48.82B
+0.32%-1.10%-23.88%+4.11% 175B
+1.12%-3.59%-5.81%+11.07% 113B
-1.68%-1.07%+2.23%+63.16% 59.13B
+1.71%+0.83%+1.03%-31.61% 48.82B
+1.49%+3.66%+12.10%+51.47% 48.69B
-0.13%-2.35%+27.75%+1.38% 33.01B
+1.69%+11.16% - - 30.41B
-0.98%+2.24%+45.56%-1.38% 26.29B
-1.58%+7.22%+21.72%-6.35% 23.87B
Average +0.21%+1.64%+10.09%+11.48% 62.04B
Weighted average by Cap. +0.38%-0.27%-2.71%+12.37%

Financials

2026 *2027 *
Net sales 19.26B 16.9B 15.96B 14.55B 27.23B 1,846B 27.43B 191B 73.98B 943B 72.32B 70.75B 3,031B 19.73B 17.32B 16.35B 14.9B 27.9B 1,891B 28.1B 196B 75.8B 966B 74.09B 72.49B 3,105B
Net income 1.44B 1.26B 1.19B 1.09B 2.03B 138B 2.05B 14.25B 5.52B 70.34B 5.39B 5.28B 226B 2.34B 2.05B 1.94B 1.77B 3.31B 224B 3.33B 23.2B 8.99B 115B 8.78B 8.59B 368B
Net Debt 15.88B 13.94B 13.16B 12B 22.46B 1,522B 22.62B 158B 61.02B 778B 59.64B 58.35B 2,500B 13.95B 12.24B 11.56B 10.54B 19.72B 1,337B 19.87B 138B 53.59B 683B 52.38B 51.25B 2,196B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change
23/09/26 €159.95 -0.40%
23/09/26 €160.60 +0.94%
22/09/26 €159.10 +1.27%
21/09/26 €157.10 -0.10%
18/09/26 €157.25 -1.32%
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
179.23USD
Average target price
195.67USD
Spread / Average Target
+9.17%

Quarterly revenue - Rate of surprise